LIGATURE THERAPEUTICS

Ligature Therapeutics is an early-stage biotechnology company that develops small molecule “protein degrader” therapeutics. Ligature Therapeutics is an early-stage drug discovery company that takes a novel approach towards developing small molecules for targeted protein degradation to treat intractable diseases. Ligature Therapeutics was founded by doctors Alvin Hung, Thomas Keller, and Congbao Kang with initial investment from Lightstone Singapore, a Singapore-focused venture fund founded in 2016 by Lightstone Ventures.

#People #Financial #More

LIGATURE THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Medical Therapeutics

Founded:

2020-01-01

Address:

Singapore, Central Region, Singapore

Country:

Singapore

Status:

Active

Total Funding:

6 M USD

Current Employees Featured

not_available_image

Alvin Hung
Alvin Hung VP Chemistry @ Ligature Therapeutics
VP Chemistry
2021-02-01

not_available_image

Thomas Keller
Thomas Keller Co-founder @ Ligature Therapeutics
Co-founder

not_available_image

Congbao Kang
Congbao Kang Co-founder @ Ligature Therapeutics
Co-founder

Founder

not_available_image

Alvin Hung

not_available_image

Congbao Kang

not_available_image

Thomas Keller

Investors List

lightstone-ventures_image

Lightstone Ventures

Lightstone Ventures investment in Seed Round - Ligature Therapeutics

seeds-capital_image

Seeds Capital

Seeds Capital investment in Seed Round - Ligature Therapeutics

More informations about "Ligature Therapeutics" on Search Engine